Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
The growing use of precision medicine and genomics drives the sector. The global next-generation sequencing services market is expected to reach $8.77b by 2030 at a compound annual growth rate (CAGR) ...
Introduction While pathogen genomics using next-generation sequencing (NGS) has been recommended by the WHO as an essential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results